File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP).

TitlePrevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
Authors
Issue Date2002
Citation
MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control, 2002, v. 51, n. RR-3, p. 1-31 How to Cite?
AbstractThis report updates the 2001 recommendations by the Advisory Committee on Immunization Practices (ACIP) regarding the use of influenza vaccine and antiviral agents (MMWR 2001;50 [No. RR-4]:1-44). The 2002 recommendations include new or updated information regarding 1) the timing of influenza vaccination by risk group; 2) influenza vaccine for children aged 6-23 months; 3) the 2002-2003 trivalent vaccine virus strains: A/Moscow/10/99 (H3N2)-like, A/New Caledonia/20/99 (H1N1)-like, and B/Hong Kong/330/2001-like strains; and 4) availability of certain influenza vaccine doses with reduced thimerosal content. A link to this report and other information related to influenza can be accessed at the website for the Influenza Branch, Division of Viral and Rickettsial Diseases, National Center for Infectious Diseases, CDC, at http://www.cdc.gov/ncidod/diseases/flu/fluvirus.htm.
Persistent Identifierhttp://hdl.handle.net/10722/238024
ISSN
2022 Impact Factor: 33.7
2023 SCImago Journal Rankings: 14.618

 

DC FieldValueLanguage
dc.contributor.authorBridges, Carolyn B.-
dc.contributor.authorFukuda, Keiji-
dc.contributor.authorUyeki, Timothy M.-
dc.contributor.authorCox, Nancy J.-
dc.contributor.authorSingleton, James A.-
dc.date.accessioned2017-02-03T02:12:38Z-
dc.date.available2017-02-03T02:12:38Z-
dc.date.issued2002-
dc.identifier.citationMMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control, 2002, v. 51, n. RR-3, p. 1-31-
dc.identifier.issn1057-5987-
dc.identifier.urihttp://hdl.handle.net/10722/238024-
dc.description.abstractThis report updates the 2001 recommendations by the Advisory Committee on Immunization Practices (ACIP) regarding the use of influenza vaccine and antiviral agents (MMWR 2001;50 [No. RR-4]:1-44). The 2002 recommendations include new or updated information regarding 1) the timing of influenza vaccination by risk group; 2) influenza vaccine for children aged 6-23 months; 3) the 2002-2003 trivalent vaccine virus strains: A/Moscow/10/99 (H3N2)-like, A/New Caledonia/20/99 (H1N1)-like, and B/Hong Kong/330/2001-like strains; and 4) availability of certain influenza vaccine doses with reduced thimerosal content. A link to this report and other information related to influenza can be accessed at the website for the Influenza Branch, Division of Viral and Rickettsial Diseases, National Center for Infectious Diseases, CDC, at http://www.cdc.gov/ncidod/diseases/flu/fluvirus.htm.-
dc.languageeng-
dc.relation.ispartofMMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control-
dc.titlePrevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP).-
dc.typeArticle-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.pmid12002171-
dc.identifier.scopuseid_2-s2.0-0037066803-
dc.identifier.volume51-
dc.identifier.issueRR-3-
dc.identifier.spage1-
dc.identifier.epage31-
dc.identifier.issnl1057-5987-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats